XILINGIO 25/5MG TABLET is a combination of Empagliflozin and Linagliptin which belongs to the group of medicines called Antidiabetic agents. It is used to manage type II diabetes mellitus among adult patients when diet, exercise and management with other conventional medicines does not result in adequate sugar control. It is used as an adjunct therapy along with proper diet and exercise to achieve better results.         

XILINGIO 25/5MG TABLET can also be used in the management of heart complications among patients having both diabetes and heart problems. Follow proper hygiene and regular foot care as instructed by your doctor while taking XILINGIO 25/5MG TABLET. Regularly monitor your blood glucose levels as instructed by your doctor.

Before taking XILINGIO 25/5MG TABLET inform your doctor if you have any liver or kidney problems. You must also inform your doctor if you are severely dehydrated due to excessive vomiting or diarrhea recently as a precaution.  

XILINGIO 25/5MG TABLET is not recommended for use in patients with Type I diabetes. It is also not suitable for use in patients with alcoholism and in patients with diabetic ketoacidosis.

Consult your doctor before taking XILINGIO 25/5MG TABLET if you are pregnant or breastfeeding. The most common side effects of taking XILINGIO 25/5MG TABLET are vaginal infection, sore throat or nose, cough, passing more urine than normal, thirst and constipation. Consult your doctor if any of these side effects trouble you.